DexCom Reports Third Quarter 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq hits intraday record high on Alphabet boost, Mideast negotiation hopes
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
- Oil falls to two-week low as Gulf supply outlook improves
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
DexCom (DXCM) PT Raised to $170 at Stephens
November 7, 2018 8:34 AM ESTStephens analyst Chris Cooley raised the price target on DexCom (NASDAQ: DXCM) to $170.00 (from $160.00) while maintaining a Overweight rating following the company's 3Q report. Sales were in-line with Stephens' well-above consensus revenue estimate.
DXCM appears well positioned to continue to deliver... More
DexCom (DXCM) Tops Q3 EPS by 27c, Revenues Beat; Lifts FY18 Revenue Outlook Above Consensus
November 6, 2018 4:02 PM ESTDexCom (NASDAQ: DXCM) reported Q3 EPS of $0.17, $0.27 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $266.7 million versus the consensus estimate of $241.3 million.
Dexcom has maintained the strong momentum we have seen all year, with sales up 45% on a constant... More
